Search

everythinglearnresearchcommunity

for

Search:↓

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.

Injecting lab-grown hair cells into the scalp can regrow hair.

The research found that for a typical hair density, about 11 square centimeters of donor scalp is needed to get 800 hair grafts for transplantation.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Researchers created early-stage hair-like structures from skin cells, showing how these cells can self-organize, but more is needed for complete hair growth.

Human scalp hair follicles can be used to study how prolactin affects hair growth and cell death.

A new mouse model helps understand and find treatments for alopecia areata.

Adiponectin reduces inflammation and bone loss in joint replacements.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

Apremilast may help treat hair loss in alopecia areata.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Transplanted baby mouse skin cells grew normal hair using a new, efficient method.

The study concluded that the developed models are effective for studying hair growth mechanisms and testing new treatments.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Oxidative stress causes hair to gray by damaging and killing pigment cells.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Ganoderma Lucidum extract and ganoderic acid A can help prevent hair loss.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Human scalp fat stem cells showed improved cartilage-like development on a special scaffold with freeze-thaw treatment.